Form 4: Ultragenyx Pharmaceutical Executive Sells Shares
Insider Transaction (Form 4)
Theodore Alan Huizenga, SVP, Chief Accounting Officer of Ultragenyx Pharmaceutical Inc., sold 161 shares of common stock on September 3, 2026 for $13.99 per share.
Summary
- Open-market sale: disposed of 161 Common Stock at $13.99 ($2,252) on September 3, 2026; holds 69,146 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $2,252 of stock on the open market.
Insider Transactions
Theodore Alan Huizenga — Officer (SVP, Chief Accounting Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-03 | Open-market sale | Common Stock | 161 | $14 | $2.3K | 69,146 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-03 | Open-market sale (161 shares) |
Keywords
insider transaction, Form 4, RARE, Ultragenyx Pharmaceutical Inc., bearish, Theodore Alan Huizenga
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.